- Search jobs
- philadelphia pa
- economic analyst
Economic analyst Jobs in Philadelphia pa
- Promoted
Director, Global Health Economic and Outcomes Research (GHEOR)
MadrigalpharmaConshohocken, Pennsylvania, US- Promoted
- Promoted
Surveillance Analyst
VacoPhiladelphia, PA- Promoted
Senior Associate, Economic Services
KPMG-UnitedStatesPhiladelphia, PA- Promoted
Data Analyst / Senior Data Analyst
True PlatformPhiladelphia, PA, United States- Promoted
- Promoted
Vibration Analyst
IVC TechnologiesPhiladelphia, PA, United States- Promoted
Financial Analyst
Manpower Group Inc.Haddonfield, NJ, United States- Promoted
Principal Analyst
Forrester ResearchPhiladelphia, PA- Promoted
- New!
Senior Associate, Economic Services
KPMGPhiladelphia, PA, United States- Promoted
Web Analyst
PMI (Project Management Institute)Philadelphia, PA, United States- Promoted
Data Analyst
Everlight SolarPhiladelphia, PA, United States- Promoted
- New!
- Promoted
Pricing Analyst
DeloittePhiladelphia, PADirector, Global Health Economic and Outcomes Research (GHEOR)
Madrigal Pharmaceuticals CorporationConshohocken, PA, US- Promoted
Lead Economic Researcher
NasdaqPennsylvania, Philadelphia, USA- Promoted
Financial Analyst
Rothman OrthopaedicsPhiladelphia, PA, United StatesDirector, Global Health Economic and Outcomes Research (GHEOR)
MadrigalpharmaConshohocken, Pennsylvania, US- Full-time
About Madrigal :
Apply fast, check the full description by scrolling below to find out the full requirements for this role.
Madrigal is a biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy, Rezdiffra (resmetirom), was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis.
Role Overview :
The Director GHEOR will support the strategic goals of the GHEOR, Global Medical Affairs (GMA), and Global Access driving patient access with optimal pricing and reimbursement for Madrigal Pharmaceutical’s medicines, with a focus on Rezdiffra. This position directly impacts the ability to achieve business objectives on a global basis by providing strategic guidance and robust evidence development relevant to achieve optimal patient access by demonstrating the value of our medicines for liver health, with a primary focus on ex-US markets. The GHEOR Director will be responsible for developing and executing against the global integrated evidence plans and strategies including direct oversight of evidence generation activities and dissemination of technical deliverables.
Position Responsibilities :
- With HQ-based stakeholders, lead the development of the go-to-market evidence generation strategy to support the value of Rezdiffra, in close partnership with the cross-functional matrix team.
- Lead the design and execution of global HEOR studies (eg, network meta-analyses, non-interventional studies, economic models) from concept through publication.
- Lead the timely development of launch and HTA deliverables including global value dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in conjunction with the regions / countries.
- Provide strategic input into clinical trial designs (eg, patient populations, comparators, endpoints) and analysis to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
- Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
- Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.
- Prepare, edit, and review study protocols including statistical analysis plans (SAPs), for the development of database analysis, cost, and disease models.
- Lead the development of pre, peri-, and post-launch, deliverables including AMCP dossiers, global value dossiers (GVDs), economic models, systematic literature reviews, and other tools to support global reimbursement and access requirements.
- Lead and support early scientific advice opportunities with key global health technology agencies and incorporate the relevant advice into the global HEOR plan and market access plans.
- Lead the development of payer facing resources such as budget impact models, and payer presentation materials.
- Cross Functional Support / Collaboration :
Ensure all HEOR tactics are aligned cross-functionally with overall product / portfolio strategies business strategies and regulatory guidelines.
Qualifications and Skills Required :
PREFERRED QUALIFICATIONS :
TRAVEL OR ENVIRONMENT REQUIREMENTS :
Compensation :
Base salary is determined by several factors that include, but are not limited to, a successful candidate's qualifications, skills, education, experience, business needs, and market demands. The role may also be eligible for bonus, equity, and comprehensive benefits, which include flexible paid time off (PTO), medical, dental, vision, and life and disability insurance.
Madrigal is an Equal Opportunity Employer. All employment is decided on the basis of qualifications, merit, and business need. Applicants will receive consideration for employment without regard to race, ethnicity, color, religion, sex gender identity, sexual orientation, national origin, age, disability, protected veteran or disabled status, or other characteristic protected by applicable federal, state, or local law.
J-18808-Ljbffr